News items related to: Russia
-
Activists block big pharma patent on COVID-19 pill in Russia, but fight not over
Russia’s patent office made a ground-breaking decision to reject a patent application for molnupiravir, a treatment for COVID-19, which was...
-
“You will never fight a virus with hate and discrimination”
An interview with Evghenii Golosceapov, Director of Advocacy at Positive Initiative, a Moldovan NGO and partner of the Make Medicines...
-
Gilead sues Russia: Private company challenges a country’s right to protect public health
In January this year, the Russian Federation took decisive action, to put public health before the profit of private companies,...
-
Russian Federation’s updated patent law puts public health first
The Russian Federation parliament voted this week (13 April 2021) to enshrine into the law the country’s right to enact...
-
Russian government issues its first health-related compulsory license
A new year signals a new approach to access to medicines in the Russian Federation. Remdesivir, a drug patented by...
-
Russian government advised – “issue compulsory license to make generic COVID-19 drug available”
First civil society, and now a generic drug company, have asked the Russian government to issue a compulsory license on...
-
Russian patient organizations ask Gilead to disclaim patents for Truvada
On 3 September 2020, 25 patient organizations working within the HIV response in Russia published an open letter to Gilead...
-
Report: 10 years of community-monitoring of ARV procurement in Russia
ITPCru has released its latest report, providing a yearly analysis of community-monitoring of ARV procurement. The 2019 report marks 10...
-
Russian NGOs oppose Gilead’s patent for HIV drug, Truvada
Humanitarian Action with technical support from ITPCru has opposed Gilead’s patent in Russia for the combination of two antiretroviral drugs,...
-
Letter to ViiV Healthcare: No more time to waste – increase access to dolutegravir in Eastern Europe and Central Asia
Dolutegravir is an essential drug in HIV treatment, recommended by the World Health Organization (WHO). Despite the drug being approved...
